Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (280)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
15
2023
157
6.990
 Why?
Breast Neoplasms
23
2023
1870
4.840
 Why?
Antineoplastic Agents
23
2023
1891
2.790
 Why?
Immunoconjugates
7
2023
87
2.760
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2023
1360
2.730
 Why?
Pyrimidines
9
2021
376
2.600
 Why?
Receptor, ErbB-2
11
2023
302
2.060
 Why?
Protein Kinase Inhibitors
10
2022
789
1.860
 Why?
Neoplasms
14
2022
2112
1.790
 Why?
Piperazines
4
2020
313
1.790
 Why?
Paclitaxel
6
2022
192
1.700
 Why?
Camptothecin
9
2023
97
1.690
 Why?
Pyrazoles
6
2021
362
1.500
 Why?
Quinoxalines
2
2020
61
1.380
 Why?
Ovarian Neoplasms
4
2020
407
1.350
 Why?
Azepines
3
2020
73
1.320
 Why?
Antibodies, Monoclonal, Humanized
9
2021
665
1.260
 Why?
Cyclin-Dependent Kinase 4
2
2018
33
1.170
 Why?
Cyclin-Dependent Kinase 6
2
2018
37
1.160
 Why?
Histone Deacetylase Inhibitors
3
2023
198
1.060
 Why?
Neutropenia
4
2022
127
0.940
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1143
0.870
 Why?
Xenograft Model Antitumor Assays
11
2021
703
0.820
 Why?
beta Catenin
2
2020
220
0.800
 Why?
Female
48
2023
60086
0.780
 Why?
Breast Neoplasms, Male
2
2018
28
0.780
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
107
0.740
 Why?
Chemotherapy, Adjuvant
4
2023
334
0.730
 Why?
Cancer Care Facilities
1
2020
30
0.730
 Why?
Receptors, Estrogen
3
2021
372
0.730
 Why?
Maximum Tolerated Dose
9
2022
182
0.720
 Why?
Benzoxazoles
1
2020
16
0.720
 Why?
Carcinoma, Lobular
2
2018
44
0.710
 Why?
eIF-2 Kinase
1
2019
24
0.690
 Why?
Tumor Microenvironment
3
2020
424
0.670
 Why?
Humans
60
2023
115908
0.660
 Why?
Anthracyclines
3
2023
41
0.640
 Why?
Drug Resistance, Neoplasm
4
2020
638
0.630
 Why?
Aged
22
2023
19299
0.630
 Why?
Taxoids
3
2023
94
0.630
 Why?
Wnt Signaling Pathway
1
2019
147
0.610
 Why?
Carcinoma, Ductal, Breast
1
2018
76
0.600
 Why?
Aurora Kinase A
4
2020
51
0.600
 Why?
Trastuzumab
4
2023
89
0.590
 Why?
Pyrazines
2
2018
70
0.570
 Why?
Myocardial Infarction
1
2023
930
0.560
 Why?
Colonic Neoplasms
1
2018
221
0.550
 Why?
Pyridines
2
2018
425
0.540
 Why?
Neoadjuvant Therapy
1
2018
301
0.540
 Why?
Nuclear Proteins
2
2023
594
0.520
 Why?
Angiopoietin-1
1
2015
10
0.510
 Why?
Angiopoietin-2
1
2015
12
0.510
 Why?
Tumor Suppressor Protein p53
3
2016
448
0.490
 Why?
Cell Line, Tumor
9
2022
2749
0.480
 Why?
Medicare
4
2023
666
0.480
 Why?
Colorectal Neoplasms
5
2022
617
0.480
 Why?
Middle Aged
23
2021
27084
0.470
 Why?
Uterine Cervical Neoplasms
1
2017
213
0.470
 Why?
Cell Proliferation
8
2020
2196
0.430
 Why?
Adult
23
2022
30820
0.430
 Why?
Dose-Response Relationship, Drug
6
2022
1868
0.430
 Why?
Tumor Suppressor Proteins
1
2015
286
0.420
 Why?
Treatment Outcome
12
2022
9166
0.420
 Why?
Proto-Oncogene Proteins c-met
1
2013
67
0.420
 Why?
Antineoplastic Agents, Immunological
3
2019
153
0.420
 Why?
Recombinant Fusion Proteins
1
2015
616
0.410
 Why?
Point Mutation
1
2013
218
0.410
 Why?
Triazoles
1
2013
131
0.400
 Why?
Mitochondria
1
2017
753
0.390
 Why?
Angiogenesis Inhibitors
3
2018
216
0.390
 Why?
Mice, Nude
6
2020
639
0.380
 Why?
Carcinoma, Renal Cell
1
2013
167
0.380
 Why?
Neoplasm Recurrence, Local
4
2021
862
0.370
 Why?
Heart Failure
1
2023
1959
0.370
 Why?
Histones
3
2023
539
0.370
 Why?
Clinical Trials, Phase I as Topic
2
2020
47
0.360
 Why?
Neoplasm Metastasis
4
2020
526
0.360
 Why?
Biomarkers, Tumor
2
2014
1045
0.350
 Why?
Genes, BRCA2
1
2009
26
0.350
 Why?
Genes, BRCA1
1
2009
33
0.350
 Why?
Aged, 80 and over
8
2020
6438
0.350
 Why?
Molecular Targeted Therapy
3
2019
348
0.340
 Why?
BRCA2 Protein
1
2009
42
0.330
 Why?
Neoplasm Staging
5
2021
1177
0.330
 Why?
Kidney Neoplasms
1
2013
325
0.330
 Why?
Pregnancy Complications, Neoplastic
1
2009
50
0.330
 Why?
Thrombophilia
1
2009
67
0.330
 Why?
Quinolines
2
2021
129
0.320
 Why?
Aromatase Inhibitors
2
2018
49
0.310
 Why?
DNA-Binding Proteins
1
2015
1319
0.310
 Why?
Receptors, Progesterone
2
2021
319
0.300
 Why?
Antibodies, Monoclonal
3
2020
1262
0.300
 Why?
Mice
9
2021
15075
0.290
 Why?
Apoptosis
6
2022
2377
0.290
 Why?
Models, Biological
1
2014
1647
0.280
 Why?
Liver Neoplasms
1
2009
521
0.250
 Why?
Disease Models, Animal
3
2021
3582
0.240
 Why?
Lung Neoplasms
1
2017
2207
0.230
 Why?
United States
5
2023
12338
0.230
 Why?
Cyclophosphamide
2
2018
218
0.230
 Why?
Radiosurgery
2
2019
298
0.230
 Why?
Animals
11
2021
32123
0.220
 Why?
Doxorubicin
2
2018
290
0.220
 Why?
Disease Progression
4
2019
2424
0.210
 Why?
Cyclin-Dependent Kinase 9
1
2022
9
0.210
 Why?
Biopsy
2
2018
1056
0.210
 Why?
Histone Deacetylase 1
1
2022
16
0.210
 Why?
Administration, Oral
3
2022
731
0.200
 Why?
Aurora Kinases
2
2012
28
0.200
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
41
0.200
 Why?
Fluorouracil
1
2022
151
0.200
 Why?
Topoisomerase I Inhibitors
2
2022
16
0.200
 Why?
Arrhythmias, Cardiac
1
2023
275
0.190
 Why?
Acetylation
1
2022
212
0.190
 Why?
Biliary Tract Neoplasms
1
2021
20
0.190
 Why?
Male
13
2021
56128
0.190
 Why?
Immunotherapy
2
2023
480
0.190
 Why?
Androstadienes
1
2021
97
0.190
 Why?
Diarrhea
2
2019
173
0.180
 Why?
Necrosis
2
2019
211
0.180
 Why?
Fatigue
2
2022
295
0.180
 Why?
Carboplatin
1
2021
139
0.180
 Why?
Heterografts
1
2021
119
0.180
 Why?
Drug Administration Schedule
3
2017
724
0.180
 Why?
Hospitals, University
1
2021
172
0.180
 Why?
Clinical Trials as Topic
3
2016
945
0.180
 Why?
Histone Deacetylases
1
2022
196
0.180
 Why?
Benzodiazepines
1
2021
115
0.180
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
57
0.180
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
99
0.170
 Why?
Immune System
1
2021
173
0.170
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
22
0.170
 Why?
Kaplan-Meier Estimate
1
2021
819
0.170
 Why?
Tumor Cells, Cultured
1
2020
850
0.160
 Why?
Aquaporin 4
1
2019
86
0.160
 Why?
Albumins
1
2019
91
0.160
 Why?
Maintenance Chemotherapy
1
2018
22
0.160
 Why?
Antibodies, Bispecific
1
2018
33
0.160
 Why?
Nausea
1
2018
103
0.150
 Why?
Aminopyridines
1
2018
81
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2018
504
0.150
 Why?
Mice, Inbred BALB C
1
2020
1165
0.150
 Why?
Mastectomy
1
2018
99
0.150
 Why?
Breast
1
2018
139
0.150
 Why?
Drug Therapy, Combination
1
2020
961
0.150
 Why?
Radiotherapy, Adjuvant
1
2018
182
0.150
 Why?
Benzimidazoles
1
2018
137
0.150
 Why?
Purines
1
2018
159
0.150
 Why?
Topotecan
1
2017
14
0.150
 Why?
Isoflavones
1
2017
16
0.150
 Why?
Imidazoles
1
2018
215
0.150
 Why?
Nanoparticles
1
2021
318
0.140
 Why?
Calcium-Binding Proteins
1
2018
206
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2019
193
0.140
 Why?
Survival Analysis
1
2020
1221
0.140
 Why?
Carbolines
1
2017
29
0.140
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
16
0.140
 Why?
Hypertension
2
2018
1063
0.140
 Why?
Inhibitory Concentration 50
2
2016
78
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
65
0.140
 Why?
Insulin-Like Growth Factor I
1
2018
281
0.140
 Why?
Cell Survival
1
2019
1026
0.130
 Why?
GPI-Linked Proteins
1
2016
54
0.130
 Why?
Adaptor Proteins, Signal Transducing
1
2018
376
0.130
 Why?
Neoplasms, Second Primary
1
2016
91
0.130
 Why?
Retrospective Studies
3
2021
12616
0.130
 Why?
Tumor Protein p73
1
2015
15
0.130
 Why?
Antibodies, Neoplasm
1
2015
29
0.130
 Why?
Phosphorylation
1
2019
1561
0.130
 Why?
Hodgkin Disease
1
2016
118
0.120
 Why?
Risk Reduction Behavior
1
2016
196
0.120
 Why?
Maytansine
1
2014
13
0.120
 Why?
Demography
1
2015
264
0.120
 Why?
Survival Rate
2
2019
1653
0.120
 Why?
Brain Edema
1
2014
59
0.120
 Why?
Randomized Controlled Trials as Topic
1
2019
1216
0.120
 Why?
Drug Interactions
1
2015
347
0.110
 Why?
Protein Kinases
1
2015
306
0.110
 Why?
Analgesics, Opioid
1
2021
785
0.110
 Why?
Sulfones
1
2014
98
0.110
 Why?
Threonine
1
2013
40
0.110
 Why?
Glycine
1
2014
156
0.110
 Why?
Time Factors
2
2020
6186
0.110
 Why?
Drug Evaluation, Preclinical
1
2013
165
0.110
 Why?
Tumor Stem Cell Assay
1
2012
33
0.110
 Why?
Drug Design
1
2013
156
0.100
 Why?
Methionine
1
2013
145
0.100
 Why?
Heterozygote
1
2013
254
0.100
 Why?
Disease-Free Survival
1
2014
621
0.100
 Why?
Treatment Failure
1
2013
333
0.100
 Why?
In Situ Hybridization, Fluorescence
1
2013
310
0.100
 Why?
Computational Biology
1
2015
528
0.100
 Why?
Neovascularization, Pathologic
1
2013
283
0.100
 Why?
Risk Assessment
1
2020
3004
0.100
 Why?
Cellular Senescence
1
2012
153
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
312
0.100
 Why?
Cluster Analysis
1
2012
466
0.090
 Why?
Carcinoma in Situ
1
2011
44
0.090
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
225
0.090
 Why?
Colorado
1
2020
4122
0.090
 Why?
Mutation
2
2012
3371
0.090
 Why?
Brain Neoplasms
2
2019
979
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
88
0.090
 Why?
Sequence Analysis, DNA
1
2013
733
0.090
 Why?
Tumor Burden
1
2010
261
0.090
 Why?
Pregnancy Trimester, Second
1
2009
66
0.080
 Why?
Keratinocytes
1
2010
218
0.080
 Why?
Mastectomy, Segmental
1
2009
76
0.080
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
67
0.080
 Why?
Pregnancy Trimester, First
1
2009
129
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
175
0.080
 Why?
Lymph Node Excision
1
2009
140
0.080
 Why?
Risk Factors
1
2020
8714
0.070
 Why?
Prognosis
2
2018
3342
0.070
 Why?
Cell Adhesion Molecules
2
2019
169
0.070
 Why?
Infusions, Intravenous
2
2019
374
0.070
 Why?
Risk
1
2009
830
0.070
 Why?
Antigens, Neoplasm
2
2019
224
0.070
 Why?
CD8-Positive T-Lymphocytes
2
2023
686
0.070
 Why?
Gene Expression Profiling
1
2012
1548
0.070
 Why?
Cell Cycle Proteins
2
2023
555
0.060
 Why?
Cell Cycle
2
2018
546
0.060
 Why?
Combined Modality Therapy
2
2019
1128
0.060
 Why?
Signal Transduction
2
2014
4526
0.050
 Why?
Mesylates
1
2022
8
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
63
0.050
 Why?
Clinical Protocols
1
2023
233
0.050
 Why?
Liver
1
2009
1693
0.050
 Why?
Chimerism
1
2021
28
0.050
 Why?
Lymphoid Tissue
1
2021
63
0.050
 Why?
Lymphocyte Subsets
1
2021
78
0.050
 Why?
Mice, SCID
1
2021
321
0.040
 Why?
SEER Program
1
2021
193
0.040
 Why?
Hormones
1
2020
132
0.040
 Why?
Mice, Inbred NOD
1
2021
562
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Infant, Newborn
1
2009
5089
0.040
 Why?
Tissue Distribution
1
2018
324
0.040
 Why?
Anemia
1
2019
144
0.040
 Why?
Pregnancy
1
2009
5556
0.040
 Why?
Cetuximab
1
2016
90
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
107
0.030
 Why?
Retreatment
1
2016
70
0.030
 Why?
Neoplasm Transplantation
1
2016
235
0.030
 Why?
Platinum
1
2016
40
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
180
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
524
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
228
0.030
 Why?
Transcription Factors
1
2023
1531
0.030
 Why?
Biomarkers
2
2016
3474
0.030
 Why?
History, Ancient
1
2015
51
0.030
 Why?
Mice, Knockout
1
2021
2606
0.030
 Why?
Databases, Genetic
1
2015
200
0.030
 Why?
DNA Damage
1
2017
356
0.030
 Why?
Opioid-Related Disorders
1
2021
423
0.030
 Why?
Phenotype
1
2021
2861
0.030
 Why?
Drug Combinations
1
2013
288
0.030
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
389
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
242
0.030
 Why?
Immunohistochemistry
1
2016
1643
0.020
 Why?
Cohort Studies
1
2021
4960
0.020
 Why?
Transcription, Genetic
1
2017
1318
0.020
 Why?
Biopsy, Needle
1
2011
183
0.020
 Why?
Enzyme Inhibitors
1
2014
758
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Proto-Oncogene Proteins
1
2014
609
0.020
 Why?
ErbB Receptors
1
2013
557
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
394
0.020
 Why?
Ki-67 Antigen
1
2010
104
0.020
 Why?
Patient Selection
1
2013
656
0.020
 Why?
Capillary Permeability
1
2010
138
0.020
 Why?
Follow-Up Studies
1
2018
4446
0.020
 Why?
Patient Satisfaction
1
2013
585
0.020
 Why?
Membrane Proteins
1
2015
1033
0.020
 Why?
Positron-Emission Tomography
1
2010
290
0.020
 Why?
Algorithms
1
2015
1494
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3087
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2409
0.020
 Why?
Brain
1
2014
2382
0.010
 Why?
Young Adult
1
2014
10518
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (280) concept(s)
_
Co-Authors Expand Description
See all (58) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)